| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Cancer Biology |
Divisions of 1 Tissue Remodelling and Repair and 2 Cancer Sciences, University of Southampton, Southampton General Hospital, Southampton, United Kingdom
Purpose: The purpose of this study was to determine the role of functional interactions between pancreatic cancer cells and pancreatic stellate cells (PSCs) in the formation of the desmoplastic reaction (DR) in pancreatic cancer and to characterize the effect of type I collagen (the predominant component of the DR) on pancreatic cancer cell phenotype.
Experimental Design: PSCs and type I collagen were identified in sections of pancreatic cancer using immunohistochemistry, and their anatomic relationship was studied. Interactions among pancreatic cancer cell lines (MIA PaCa-2, Panc-1, and AsPC-1), primary cultures of human PSCs, and type I collagen were investigated in a series of tissue culture models.
Results: In vivo, the DR causes gross distortion of normal pancreas, bringing cancer cells into close contact with numerous PSCs and abundant type I collagen. In tissue culture models of pancreatic cancer, conditioned media from each cell line increased PSC [3H]thymidine incorporation up to 6.3-fold that of controls, and AsPC-1 cells also increased PSC collagen synthesis 1.3-fold. Type I collagen was observed to increase long-term survival of pancreatic cancer cells treated with 5-fluorouracil, by up to 62% in clonogenic assays. This was because type I collagen increased the proliferation of cancer cells ([3H]thymidine incorporation was up to 2.8-fold that of cells cultured on tissue culture plastic) and reduced apoptosis of AsPC-1 cells in response to 5-fluorouracil (by regulating mcl-1).
Conclusions: These experiments elucidate a mechanism by which the DR in pancreatic cancer may form and, via the collagen within it, promote the malignant phenotype of pancreatic cancer cells, suggesting significant detriment to the host.
This article has been cited by other articles:
![]() |
J. H. McCarty {alpha}v Integrins Lead the Way for Colorectal Metastases Clin. Cancer Res., October 15, 2008; 14(20): 6351 - 6353. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Conti, T. J. Kendall, A. Bateman, T. A. Armstrong, A. Papa-Adams, Q. Xu, G. Packham, J. N. Primrose, R. C. Benyon, and J. P. Iredale The Desmoplastic Reaction Surrounding Hepatic Colorectal Adenocarcinoma Metastases Aids Tumor Growth and Survival via {alpha}v Integrin Ligation Clin. Cancer Res., October 15, 2008; 14(20): 6405 - 6413. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Shintani, Y. Fukumoto, N. Chaika, R. Svoboda, M. J. Wheelock, and K. R. Johnson Collagen I-mediated up-regulation of N-cadherin requires cooperative signals from integrins and discoidin domain receptor 1 J. Cell Biol., March 24, 2008; 180(6): 1277 - 1289. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Mahadevan and D. D. Von Hoff Tumor-stroma interactions in pancreatic ductal adenocarcinoma Mol. Cancer Ther., April 1, 2007; 6(4): 1186 - 1197. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Shintani, M. A. Hollingsworth, M. J. Wheelock, and K. R. Johnson Collagen I Promotes Metastasis in Pancreatic Cancer by Activating c-Jun NH2-Terminal Kinase 1 and Up-regulating N-Cadherin Expression Cancer Res., December 15, 2006; 66(24): 11745 - 11753. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Ottaviano, L. Sun, V. Ananthanarayanan, and H. G. Munshi Extracellular Matrix-Mediated Membrane-Type 1 Matrix Metalloproteinase Expression in Pancreatic Ductal Cells Is Regulated by Transforming Growth Factor-{beta}1. Cancer Res., July 15, 2006; 66(14): 7032 - 7040. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Aikawa, J. Gunn, S. M. Spong, S. J. Klaus, and M. Korc Connective tissue growth factor-specific antibody attenuates tumor growth, metastasis, and angiogenesis in an orthotopic mouse model of pancreatic cancer Mol. Cancer Ther., May 1, 2006; 5(5): 1108 - 1116. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Pinzani Pancreatic stellate cells: new kids become mature Gut, January 1, 2006; 55(1): 12 - 14. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |